Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Teva Pharmaceuticals Industries LtD
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
Dose finding study to evaluate the pharmacodynamics, pharmacokinetics, efficacy and safety of balugrastim in pediatric patients diagnosed with solid tumors receiving chemotherapy. Dóziskereső vizsgálat, amely a balugrastim farmakodinámiáját, farmakokinetikáját, hatásosságát és biztonságosságát kutatja szolid tumorral diagnosztizált, és kemoterápiás kezelésben részesülő gyermek betegek esetében
The primary objective of this study is to find the optimal dose of balugrastim by characterizing its pharmacokinetics (PK), and by comparing the pharmacodynamics (PD) of balugrastim to filgrastim duri...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
A Multicenter, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson’s Disease Subjects. Estudio multicéntrico, doble ciego, de inicio randomizado, controlado con placebo, de grupos paralelos, para valorar Rasagilina como una terapia que modifica la enfermedad de Parkinson en pacientes con enfermedad de Parkinson en fase temprana
To assess rasagiline as a disease modifying therapy in early PD
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
A PHASE I, DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED (WITHIN EACH GROUP) STUDY TO EVALUATE THE INTERACTION BETWEEN ORALLY ADMINISTERED TYRAMINE HYDROCHLORIDE AND RASAGILINE MESILATE IN HEALTHY SUBJECTS
To assess tyramine sensitivity when administered with rasagiline, and the selectivity of rasagiline for monoamine oxidase type B (MAO-B)
Country
None
organs
None
Specialty
None
unknown
More information